Development and validation of a computational histology artificial intelligence (CHAI) prognostic biomarker in renal cell carcinoma.
Alex Zihao Zhu(University of Washington), Sumanta Kumar Pal(City of Hope), Lesli A. Kiedrowski(Guardant (United States)), Anirudh Joshi, Trevor J. Royce, Gaurav Kaul, Vrishab Krishna, Viswesh Krishna(Vale (Brazil)), Snehal Shankar Sonawane, Vivek Nimgaonkar
Cited by 0
Related Papers
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer
|Cell Reports Medicine|2023|19
TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysis
|Therapeutic Advances in Medical Oncology|2023|11